{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:37:00Z","timestamp":1784770620346,"version":"3.55.0"},"reference-count":29,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cephalalgia"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The role of angiotensin II receptor blockers (ARBs) in migraine prophylaxis varies globally, partly due to insufficient evidence from randomized controlled trials (RCTs) supporting their efficacy. We aimed to conduct a systematic review and meta-analysis of ARBs in migraine prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We searched PubMed\/MEDLINE, Embase, Cochrane, Google Scholar, Clinicaltrials.gov, ITCRP, and EudraCT from database inception to 22 September 2025. The searches were conducted between 19 and 22 September 2025 for controlled trials comparing any ARB to placebo or other preventive migraine drugs in individuals with episodic or chronic migraine. Guidelines, letters, editorials, narrative reviews, case reports, and news were excluded. Summary data were extracted by two reviewers, and random-effects meta-analyses were performed, with heterogeneity assessed using Cochrane I\n                      <jats:sup>2<\/jats:sup>\n                      statistic. Primary outcomes were monthly headache\/migraine days or attacks, and response rates. Adverse event occurrence was also assessed. The risk of bias was assessed using the Cochrane RoB2 tool and the certainty of evidence was assessed using GRADEpro. The study was pre-registered in Prospero (CRD42023405372) and received no funding.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four trials published between 2003 and 2025 were included in the meta-analysis: three RCTs on candesartan, and one on telmisartan. All four studies reported the outcomes migraine days and responder (\u226550% reduction of migraine days) rates, and three reported headache days. A total of 659 participants were included in the meta-analysis. The combined effect size for migraine days and headache days were reductions of \u22121.00 (95% CI: \u22121.51 to \u22120.49, p&lt;0.001), and \u22121.21 (95% CI: \u22121.62 to \u22120.81, p&lt;0.001) days per month from baseline respectively. The odds ratio for being a responder was 2.68 (95% CI: 1.91 to 3.78, p&lt;0.001). The certainty of evidence was low for migraine days, moderate for responder rates and high for headache days, with heterogeneity between studies categorized as \u2018might not be important\u2019 and no serious risk of bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The systematic review and meta-analysis provide robust evidence on the effect of ARBs, particularly candesartan, in prevention of episodic migraine, supporting the rationale for reconsidering its position in international guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>Prospero CRD42023405372<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03331024261451481","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:40:04Z","timestamp":1780069204000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["The effects of angiotensin receptor blockers as prophylactic migraine treatment: A systematic review and meta-analysis"],"prefix":"10.1177","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7810-7882","authenticated-orcid":false,"given":"Hedda Skogum","family":"Riise","sequence":"first","affiliation":[{"name":"Norwegian University of Science and Technology (NTNU)"},{"name":"Department of Neurology and Neurophysiology, St Olavs hospital, Trondheim University Hospital"},{"name":"Norwegian University of Science and Technology (NTNU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8454-116X","authenticated-orcid":false,"given":"Helene","family":"Thorvik","sequence":"additional","affiliation":[{"name":"Norwegian University of Science and Technology (NTNU)"},{"name":"Department of Neurology and Neurophysiology, St Olavs hospital, Trondheim University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9844-4651","authenticated-orcid":false,"given":"Lise Rystad","family":"\u00d8ie","sequence":"additional","affiliation":[{"name":"Norwegian University of Science and Technology (NTNU)"},{"name":"Department of Neurology and Neurophysiology, St Olavs hospital, Trondheim University Hospital"},{"name":"Norwegian University of Science and Technology (NTNU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-5892","authenticated-orcid":false,"given":"Lars Jacob","family":"Stovner","sequence":"additional","affiliation":[{"name":"Norwegian University of Science and Technology (NTNU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6059-0151","authenticated-orcid":false,"given":"Erling Andreas","family":"Tronvik","sequence":"additional","affiliation":[{"name":"Norwegian University of Science and Technology (NTNU)"},{"name":"Department of Neurology and Neurophysiology, St Olavs hospital, Trondheim University Hospital"},{"name":"Norwegian University of Science and Technology (NTNU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4799-9534","authenticated-orcid":false,"given":"Mattias","family":"Linde","sequence":"additional","affiliation":[{"name":"Norwegian University of Science and Technology (NTNU)"},{"name":"Norwegian University of Science and Technology (NTNU)"},{"name":"Sahlgrenska University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Hagen","sequence":"additional","affiliation":[{"name":"Norwegian University of Science and Technology (NTNU)"},{"name":"Department of Neurology and Neurophysiology, St Olavs hospital, Trondheim University Hospital"},{"name":"Norwegian University of Science and Technology (NTNU)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4464-4951","authenticated-orcid":false,"given":"Samita","family":"Giri","sequence":"additional","affiliation":[{"name":"Norwegian University of Science and Technology (NTNU)"},{"name":"Department of Neurology and Neurophysiology, St Olavs hospital, Trondheim University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-123X","authenticated-orcid":false,"given":"Tore","family":"Wergeland","sequence":"additional","affiliation":[{"name":"Norwegian University of Science and Technology (NTNU)"},{"name":"Department of Neurology and Neurophysiology, St Olavs hospital, Trondheim University Hospital"},{"name":"Norwegian University of Science and Technology (NTNU)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00509-5"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.14692"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/ncn3.70042"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/03331024251321500"},{"key":"e_1_3_3_6_2","volume-title":"StatPearls","author":"Bulsara KG","year":"2025","unstructured":"Bulsara KG, Patel P, Makaryus AN. Candesartan. In: StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC., 2025."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130733"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231183166"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(25)00269-8"},{"key":"e_1_3_3_10_2","unstructured":"Higgins JPT Chandler J Cumpston M et al. (eds) Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024). Cochrane www.cochrane.org\/handbook (2024)."},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_3_12_2","unstructured":"PICO Portal St. Petersburg FL United States. www.picoportal.org."},{"key":"e_1_3_3_13_2","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JAC","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. Rob 2: a revised tool for assessing risk of bias in randomised trials. Br Med J 2019; 366: l4898.","journal-title":"Br Med J"},{"key":"e_1_3_3_14_2","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.5","author":"Higgins JPTSJ","year":"2024","unstructured":"Higgins JPTSJ, Page MJ, Elbers RG, et al. Chapter 8: Assessing risk of bias in a randomized trial [last updated October 2019]. In: Higgins JPT, Thomas J, Chandler J, etal (eds) Cochrane handbook for systematic reviews of interventions version 6.5. London, UK: Cochrane, 2024."},{"key":"e_1_3_3_15_2","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.5","author":"Higgins JPTES","year":"2024","unstructured":"Higgins JPTES, Li T. Chapter 23: Including variants on randomized trials [last updated October 2019]. In: Higgins JPT, Thomas J, Chandler J, etal (eds) Cochrane handbook for systematic reviews of interventions version 6.5. London, UK: Cochranecochrane.org\/handbook2024."},{"key":"e_1_3_3_16_2","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.5","author":"Sch\u00fcnemann HJHJ","year":"2024","unstructured":"Sch\u00fcnemann HJHJ, Vist GE, Glasziou P, et al. Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence [last updated August 2023]. In: Higgins JPT, Thomas J, Chandler J, etal (eds) Cochrane handbook for systematic reviews of interventions version 6.5. London, UK: Cochrane, 2024."},{"key":"e_1_3_3_17_2","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University and Evidence Prime gradepro.org (2023)."},{"key":"e_1_3_3_18_2","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.5","author":"Deeks JJ","year":"2024","unstructured":"Deeks JJ, Higgins JP, Altman DG, et al. Chapter 10: Analysing data and undertaking meta-analysies [last updated November 2014]. In: Higgins JP, Thomas J, Chandler J, etal (eds) Cochrane handbook for systematic reviews of interventions version 6.5. London, UK: Cochrane, 2024."},{"key":"e_1_3_3_19_2","unstructured":"Abisalam SH. Comparison of onabotulinumtoxin A with other prophylactic treatments (amitriptyline topiramate and candesartan) of chronic migraine. 2nd International Conference on Central Nervous System Disorders & Therapeutics. Dubai UAE 2016."},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.1.65"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413515348"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01825.x"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1630732"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmn.2024.07.001"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2000.00117.x"},{"key":"e_1_3_3_26_2","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Clinical safety data management: definitions and standards for expedited reporting E2A. 1994."},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-019-0823-8"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.70061"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241248833"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83508-2"}],"container-title":["Cephalalgia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03331024261451481","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03331024261451481","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03331024261451481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T06:16:21Z","timestamp":1780294581000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03331024261451481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1177\/03331024261451481"],"URL":"https:\/\/doi.org\/10.1177\/03331024261451481","relation":{},"ISSN":["0333-1024","1468-2982"],"issn-type":[{"value":"0333-1024","type":"print"},{"value":"1468-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"article-number":"03331024261451481"}}